- The therapy of ocular manifestations of immune mediated inflammatory diseases2019 | First Faculty of Medicine
- Switching to biosimilars: current perspectives in immune-mediated inflammatory diseases2019 | Second Faculty of Medicine
- On the question of the interchangeability of monoclonal biosimilar antibodies in the treatment of immune-mediated inflammatory diseases2023 | First Faculty of Medicine, Third Faculty of Medicine
- Immune-Mediated Intraocular Inflammation. A review2021 | First Faculty of Medicine
- Guidelines for the administration of biological therapy in patients with inflammatory bowel diseases: 2nd edition2012 | Faculty of Medicine in Hradec Králové, Central Library of Charles University, Faculty of Medicine in Pilsen, First Faculty of Medicine
- Successful treatment with adalimumab in a patient with psoriasis, acne and sacroiliitis2023 | First Faculty of Medicine
- Paricalcitol (19-nor-1,25-dihydroxycholecalciferol) and calcitriol (1,25-dihydroxycholecalciferol) exert potent immunomodulatory effects on dendritic cells and inhibit induction of antigen-specific T cells +12009 | Faculty of Medicine in Hradec Králové
- Paricalcitol (19-nor-1,25-dihydroxycholecalciferol) and calcitriol (1,25-dihydroxycholecalciferol) exert potent immunomodulatory effects on dendritic cells and inhibit induction of antigen-specific T cells2009 | First Faculty of Medicine
- Guidelines for the administration of biological therapy in patients with inflammatory bowel diseases: 2nd edition2012 | Central Library of Charles University, First Faculty of Medicine
- Biological therapy of inflammatory bowel diseases with adalimumab2019 | First Faculty of Medicine
- Hyrimoz - new biosimilars in treatment of rheumatoid arthritis2019 | Second Faculty of Medicine
- Adalimumab biosimilar-induced severe paradoxical palmoplantar pustulosis in a patient with psoriasis and psoriatic arthritis successfully treated with ixekizumab2022 | Third Faculty of Medicine
- Paradoxical Reactions to Anti-TNFα and Anti-IL-17 Treatment in Psoriasis Patients: Are Skin and/or Gut Microbiota Involved?2023 | Second Faculty of Medicine
- Paricalcitol (19-nor-1,25-dihydroxyvitamin D2) and calcitriol (1,25-dihydroxyvitamin D3) exert potent immunomodulatory effects on dendritic cells and inhibit induction of antigen-specific T cells2009 | Second Faculty of Medicine
- Paricalcitol (19-nor-) and calcitriol (1,25-dihydroxycholecalciferol) exert potent immunomodulatory effects on dendritic cells and inhibit induction of antigen-specific T cells2011 | First Faculty of Medicine, Second Faculty of Medicine, Faculty of Physical Education and Sport
- Immunogenicity and safety of the booster BNT162b2 vaccine in patients with axial spondyloarthritis treated with biological disease-modifying drugs2022 | Second Faculty of Medicine